eHealth Q3 revenue fell 60% to $21.3 million as net loss widened to $35.9 million
eHealth reported third-quarter 2026 results with total revenue of $21.3 million, down 60% from $53.9 million a year earlier, and a GAAP net loss of $35.9 million, compared with a net loss of $31.7 million in the prior-year quarter. The company reiterated its full-year 2026 guidance, which calls for total revenue of $405.0 million to $445.0 million and GAAP net income of $8.0 million to $25.0 million, and it said operating cash flow improved year over year.
Key points
- Q3 2026 total revenue was $21.3 million versus $53.9 million; adjusted EBITDA was a loss of $39.9 million versus a loss of $34.0 million.
- Q3 2026 operating cash flow was a use of $11.2 million, compared with a use of $25.3 million in Q3 2025; year-to-date operating cash flow was $19.6 million.
- Full-year 2026 guidance was reiterated: total revenue $405.0 million to $445.0 million, GAAP net income $8.0 million to $25.0 million, adjusted EBITDA $55.0 million to $75.0 million, and operating cash flow $(10.0) million to $12.0 million.
- Management said total operating costs and expenses fell 29% to $67.6 million, and it expects more than $60.0 million in annual variable spend reductions.
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.